Cancer Family
Childhood Benign Neoplasm
CI-CAN-00000122Explore in graph →
PediatricNon-malignant3 active trials
- NCIt
- C190573
Loading cancer entity…
Cancer Family
CI-CAN-00000122Explore in graph →
Clinical trials
38 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06798363 | Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile Hemangioma | recruiting | Phase 2 / Phase 3 | 32 | West China HospitalOTHER | 1 | Sep 21, 2026 | clinicaltrials |
| NCT06677853 | Timolol Maleate Gel for the Treatment of Infantile Hemangioma | completed | Phase 2 / Phase 3 | 168 | Auson Pharmaceuticals Inc.INDUSTRY | 1 | Nov 7, 2024 | clinicaltrials |
| NCT02913612 | Efficacy, Safety and Pharmacokinetics of Topical Timolol in Infants With Infantile Hemangioma (IH)(TIM01) | completed | Phase 2 | 105 | Kanecia Obie ZimmermanOTHER | 1 | Mar 12, 2024 | clinicaltrials |
| NCT01010308 | Nadolol for Proliferating Infantile Hemangiomas |
Data updated 4 days agoSource updated Sep 21, 2026source: clinicaltrials
| completed |
| Phase 2 |
| 20 |
| The Hospital for Sick ChildrenOTHER |
| 1 |
| Aug 19, 2021 |
| clinicaltrials |
| NCT04684667 | ''Efficacy of Propranolol in the Treatment of Infantile Hemangioma" | unknown | Phase 2 | 100 | Assiut UniversityOTHER | 1 | Dec 24, 2020 | clinicaltrials |
| NCT01056341 | Study to Demonstrate the Efficacy and Safety of Propranolol Oral Solution in Infants With Proliferating Infantile Hemangiomas Requiring Systemic Therapy | completed | Phase 2 / Phase 3 | 512 | Pierre Fabre DermatologyINDUSTRY | 16 | Dec 10, 2015 | clinicaltrials |
| NCT01512173 | Study in Infants With Infantile Hemangioma to Compare Propranolol Gel to Placebo | completed | Phase 2 | 82 | Pierre Fabre DermatologyINDUSTRY | 3 | Oct 30, 2014 | clinicaltrials |
| NCT00004078 | Irinotecan in Treating Children With Refractory Solid Tumors | completed | Phase 2 | 181 | Children's Oncology GroupNETWORK | 1 | Jun 14, 2013 | clinicaltrials |